Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|February 24, 2023
The research landscape of the quality of life or psychological impact on gynecological cancer patients: A bibliometric analysisJiayuan Zhao, Yujia Kong, Yang Xiang, et al.
Cancer Causes & Control : CCC|February 22, 2022
Pediatric neurological cancer incidence and trends in the United States, 2000-2018Yujia Kong, Xu Ji, Xuesong Han, et al.
Cancer Management and Research|March 19, 2019
Cervical cancer in women aged 25 years or younger: a retrospective studyYujia Kong, Liju Zong, Junjun Yang, et al.
Frontiers in Oncology|February 1, 2021
Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential AnalysisYu Gu, Hongyan Cheng, Liju Zong, et al.
The Journal of Craniofacial Surgery|August 25, 2022
Prevalence of Oral Exostoses in Northern China During the Past Six Millennia-From a Sex and Age PerspectiveMengting Lu, Ting Kang, Yujia Kong, et al.
Frontiers in Endocrinology|February 3, 2023
Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome originsXiao Qi, Qinghua Wang, Mingdong Yu, et al.
Oncotargets and Therapy|November 26, 2020
Emerging Targets of Immunotherapy in Gynecologic CancerHongyan Cheng, Liju Zong, Yujia Kong, et al.
Frontiers in Oncology|September 3, 2019
Oncological Outcomes and Safety of Ovarian Preservation for Early Stage Adenocarcinoma of Cervix: A Systematic Review and Meta-AnalysisHongyan Cheng, Lanqing Huo, Liju Zong, et al.
Cancer Causes & Control : CCC|October 16, 2022
Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: Evidence from the Surveillance, Epidemiology, and End Results registry dataPeiyi Li, Yujia Kong, Jing Guo, et al.
Human Vaccines & Immunotherapeutics|February 4, 2016
Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trialWei Zhang, Yujia Kong, Zhiwei Jiang, et al.
Pageof 6